Atlas Trials

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in ABO-Incompatible Liver Transplantation

Clinical trial NCT05666453 · TERMINATED

Trial details

NCT number
NCT05666453
Sponsor
SK Plasma Co., Ltd.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Liver Transplantation
Start date
2022-04-25
Primary completion
2024-05-07
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.